Ding Yuhua, Yao Bangtao, Ye Hui, Wang Fei
Department of Ophthalmology, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Department of Ophthalmology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China.
J Ophthalmol. 2023 Sep 28;2023:8851207. doi: 10.1155/2023/8851207. eCollection 2023.
This study aimed to investigate the main etiological factors and visual outcomes in patients with dense vitreous hemorrhage (DVH) aged ≥80 years. We retrospectively included patients with DVH aged ≥80 years who were admitted to our ophthalmology department between January 1, 2010, and December 31, 2019. All patients underwent pars plana vitrectomy (PPV). Data regarding demographic characteristics; preoperative and postoperative best-corrected visual acuity (BCVA), intraocular pressure (IOP), and ophthalmic B-scan ultrasonography findings; intraoperative conditions; and postoperative complications were collected and analyzed. A total of 44 patients (44 eyes) were enrolled, with a median age of 82 years; among them, 25 patients (56.82%) were men. The median preoperative BCVA was 2.3 (1.1-3.0). The main etiological factors included retinal vein occlusion (RVO) (20 eyes, 45.45%), polypoidal choroidal vasculopathy (PCV) (15 eyes, 34.09%), proliferative diabetic retinopathy (PDR) (7 eyes, 15.90%), retinal arterial macroaneurysm (RAM) (1 eye, 2.27%), and posterior vitreous detachment (PVD) (1 eye, 2.27%). The median final BCVA was 1.92 (0.5-2.6). There was a significant postoperative improvement in the BCVA; moreover, branch RVO (BRVO) had a better postoperative visual prognosis than central RVO (CRVO), PCV, and PDR ( < 0.05). The final postoperative BCVA was significantly better when the initial BCVA was above hand motion (HM) than when it was HM or lower ( < 0.05). Our findings indicate that RVO, PCV, and PDR were the main causes of DVH. Microinvasive PPV is a safe and effective method that can clarify diagnosis and improve BCVA. Patients with BRVO and preoperative BCVA > HM may have a relatively good visual prognosis. For patients aged ≥80 years who have an appropriate general condition, PPV can be timely performed to treat DVH.
本研究旨在调查年龄≥80岁的致密性玻璃体出血(DVH)患者的主要病因及视力预后。我们回顾性纳入了2010年1月1日至2019年12月31日期间在我院眼科住院的年龄≥80岁的DVH患者。所有患者均接受了玻璃体切割术(PPV)。收集并分析了患者的人口统计学特征、术前和术后最佳矫正视力(BCVA)、眼压(IOP)、眼科B超检查结果、术中情况及术后并发症等数据。共纳入44例患者(44只眼),中位年龄为82岁;其中男性25例(56.82%)。术前BCVA中位数为2.3(1.1 - 3.0)。主要病因包括视网膜静脉阻塞(RVO)(20只眼,45.45%)、息肉样脉络膜血管病变(PCV)(15只眼,34.09%)、增殖性糖尿病视网膜病变(PDR)(7只眼,15.90%)、视网膜动脉大动脉瘤(RAM)(1只眼,2.27%)和玻璃体后脱离(PVD)(1只眼,2.27%)。最终BCVA中位数为1.92(0.5 - 2.6)。术后BCVA有显著改善;此外,分支RVO(BRVO)的术后视力预后优于中央RVO(CRVO)、PCV和PDR(P < 0.05)。初始BCVA高于手动(HM)时的最终术后BCVA明显优于初始BCVA为HM或更低时(P < 0.05)。我们的研究结果表明,RVO、PCV和PDR是DVH的主要原因。微创PPV是一种安全有效的方法,可明确诊断并改善BCVA。BRVO且术前BCVA > HM的患者可能有相对较好的视力预后。对于年龄≥80岁且全身状况适宜的患者,可及时进行PPV治疗DVH。